Anteris Technologies (ASX:AVR) reports marked improvements of first-in-human DurAVR study at six-month mark
Anteris Technologies (AVR) reports marked improvements since the three-month follow-up of its…
Anteris Technologies Ltd (ASX:AVR)
About Anteris Technologies Ltd
Key Information
AVR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 23/06/2022 | Application for quotation of securities - AVR | 29.71KB | 282 |
| 21/06/2022 | Price Sensitive PS DurAVR First In Human Patient 6 Month Study Follow Up | 166.17KB | 17K |
| 17/06/2022 | Cleansing Notice | 159.76KB | 222 |
| 17/06/2022 | Application for quotation of securities - AVR | 36.19KB | 176 |
| 17/06/2022 | Change of Director's Interest Notice x4 | 344.78KB | 2.5K |
| 17/06/2022 | Notification regarding unquoted securities - AVR | 36.55KB | 186 |
| 10/06/2022 | Cleansing Notice | 158.86KB | 277 |
| 10/06/2022 | Application for quotation of securities - AVR | 33.42KB | 264 |